Single Molecule Force Spectroscopy Reveals Distinctions in Key Biophysical Parameters of αβ T-Cell Receptors Compared with Chimeric Antigen Receptors Directed at the Same Ligand.
Debasis BanikMaryam HamidiniaJoanna BrzostekLing WuHannah M StephensPaul A MacAryEllis L ReinherzNicholas R J GascoigneMatthew J LangPublished in: The journal of physical chemistry letters (2021)
Chimeric antigen receptor (CAR) T-cell therapies exploit facile antibody-mediated targeting to elicit useful immune responses in patients. This work directly compares binding profiles of CAR and αβ T-cell receptors (TCR) with single cell and single molecule optical trap measurements against a shared ligand. DNA-tethered measurements of peptide-major histocompatibility complex (pMHC) ligand interaction in both CAR and TCR exhibit catch bonds with specific peptide agonist peaking at 25 and 14 pN, respectively. While a conformational transition is regularly seen in TCR-pMHC systems, that of CAR-pMHC systems is dissimilar, being infrequent, of lower magnitude, and irreversible. Slip bonds are observed with CD19-specific CAR T-cells and with a monoclonal antibody mapping to the MHC α2 helix but indifferent to the bound peptide. Collectively, these findings suggest that the CAR-pMHC interface underpins the CAR catch bond response to pMHC ligands in contradistinction to slip bonds for CARs targeting canonical ligands.
Keyphrases
- single molecule
- living cells
- atomic force microscopy
- immune response
- monoclonal antibody
- high resolution
- end stage renal disease
- regulatory t cells
- chronic kidney disease
- newly diagnosed
- ejection fraction
- cancer therapy
- peritoneal dialysis
- bone marrow
- drug delivery
- mesenchymal stem cells
- quantum dots
- transcription factor
- dna binding
- circulating tumor cells
- patient reported outcomes